Liu Jinming,Cha Mi Young,Li Gong,Li Zhanmei,Qiu Hongjuan,Kim Maengsup
申请号：
NZ71872814
公开号：
NZ718728A
申请日:
2014.09.18
申请国别(地区):
NZ
年份:
2017
代理人:
摘要：
The present invention relates to a compound inhibiting the activities of Bruton’s tyrosine kinase (BTK) and/or Janus kinase 3 (JAK3), a pharmaceutical composition of the compound, pharmaceutical applications of same, a method for using the compound in inhibiting the activities of BTK and/or JAK3, and a method for using the compound in treatment and/or prevention of BTK- and/or JAK3-mediated diseases or disorders in mammals (especially human). The compound is as represented by structural formula (I).
